DMO-CAP inhibits influenza virus replication by activating heme oxygenase-1-mediated IFN response

BACKGROUND: As a leading cause of respiratory disease, influenza A virus (IAV) infection remains a pandemic threat in annual seasonal outbreaks. Given the limitation of existing anti-influenza therapeutic drugs, development of new drugs is urgently required. Flavonoids extracted from Artemisia rupes...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Virol J
Autors principals: Zhong, Ming, Wang, Huiqiang, Ma, Linlin, Yan, Haiyan, Wu, Shuo, Gu, Zhengyi, Li, Yuhuan
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6381609/
https://ncbi.nlm.nih.gov/pubmed/30786886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-019-1125-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars